Evaluation of the non-specific effects of Bacille Calmette-Guérin (BCG) vaccination in healthy UK adults nork Wilkie, M

TB vaccine development: where are we and why is it so difficult? nork Wilkie, M, Mcshane, H

Vaccines nork Minhinnick, A, Wilkie, M, McShane, H

Methylene tetrahydrofolate reductase genotype modifies the chemopreventive effect of folate in colorectal adenoma, but not colorectal cancer. nork Lightfoot, T, Barrett, J, Bishop, T, Northwood, E, Smith, G, Wilkie, M, Steele, R, Carey, F, Key, T, Wolf, R, Forman, D

Optimization of a human bacille Calmette-Guerin challenge model: a tool to evaluate antimycobacterial immunity nork Minhinnick, A, Harris, S, Wilkie, M, Peter, J, Stockdale, L, Manjaly-Thomas, Z, Vermaak, S, Satti, I, Moss, P, McShane, H

Optimisation of a human BCG challenge model nork Wilkie, M, Minhinnick, A, Harris, S, Peter, J, Stockdale, L, Manjaly-Thomas, Z, Vermaak, S, Satti, I, Moss, P, McShane, H

Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells nork Tanner, R, Smith, SG, Van Meijgaarden, KE, Giannoni, F, Wilkie, M, Gabriele, L, Palma, C, Dockrell, HM, Ottenhoff, THM, McShane, H

Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial nork Manjaly Thomas, Z, Satti, I, Marshall, J, Harris, S, Lopez Ramon, R, Hamidi, A, Minhinnick, A, Riste, M, Stockdale, L, Lawrie, A, Vermaak, S, Wilkie, M, Bettinson, H, McShane, H

Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study nork Wilkie, M, Tanner, R, Wright, D, Lopez Ramon, R, Beglov, J, Riste, M, Marshall, JL, Harris, SA, Bettencourt, PJG, Hamidi, A, van Diemen, PM, Moss, P, Satti, I, Wyllie, D, McShane, H

Induction of functional specific antibodies, IgG-secreting plasmablasts and memory B cells following BCG vaccination nork Bitencourt, J, Peralta-Álvarez, MP, Wilkie, M, Jacobs, A, Wright, D, Salman Almujri, S, Li, S, Harris, SA, Smith, SG, Elias, SC, White, AD, Satti, I, Sharpe, SS, O'Shea, MK, McShane, H, Tanner, RL

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults. nork Minhinnick, A, Satti, I, Harris, S, Wilkie, M, Sheehan, S, Stockdale, L, Lopez-Ramon, R, Poulton, I, Lawrie, A, Vermaak, S, Le Vert, A, Del Campo, J, Hill, F, Moss, P, McShane, H, Manjaly Thomas, Z

A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults nork Wilkie, M, Satti, I, Minhinnick, A, Harris, S, Riste, M, Ramon, R, Sheehan, S, Thomas, Z, Wright, D, Stockdale, L, Hamidi, A, O'Shea, M, Dwivedi, K, Behrens, H, Davenne, T, Morton, J, Vermaak, S, Lawrie, A, Moss, P, McShane, H

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated... nork Sheehan, S, Harris, SA, Satti, I, Hokey, DA, Dheenadhayalan, V, Stockdale, L, Thomas, Z-R, Minhinnick, A, Wilkie, M, Vermaak, S, Meyer, J, O'Shea, MK, Pau, MG, Versteege, I, Douoguih, M, Hendriks, J, Sadoff, J, Landry, B, Moss, P, McShane, H

Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults nork Riste, M, Marshall, JL, Satti, I, Harris, SA, Wilkie, M, Lopez Ramon, R, Wright, D, Wittenberg, RE, Vermaak, S, Powell Doherty, R, Lawrie, A, Conlon, CP, Cosgrove, C, Gleeson, F, Lipman, M, Moss, P, Perrin, F, Dedicoat, M, Bettinson, H, McShane, H

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-... nork Satti, I, Marshall, JL, Harris, SA, Wittenberg, R, Tanner, R, Lopez Ramon, R, Wilkie, M, Ramos Lopez, F, Riste, M, Wright, D, Peralta Alvarez, MP, Williams, N, Morrison, H, Stylianou, E, Folegatti, P, Jenkin, D, Vermaak, S, Rask, L, Cabrera Puig, I, Powell Doherty, R, Lawrie, A, Moss, P, Hinks, T, Bettinson, H, McShane, H

A monovalent chimpanzee adenovirus Ebola vaccine — preliminary report nork Rampling, T, Ewer, K, Bowyer, G, Wright, D, Imoukhuede, E, Payne, R, Hartnell, F, Gibani, M, Bliss, C, Minhinnick, A, Wilkie, M, Venkatraman, N, Poulton, I, Lella, N, Roberts, R, Sierra-Davidson, K, Krähling, V, Berrie, E, Roman, F, De Ryck, I, Nicosia, A, Sullivan, N, Stanley, D, Ledgerwood, J, Schwartz, R, Siani, L, Colloca, S, Folgori, A, Di Marco, S, Cortese, R, Becker, S, Graham, B, Koup, R, Levine, M, Moorthy, V, Pollard, A, Draper, S, Ballou, W, Lawrie, A, Gilbert, S, Hill, A

A monovalent chimpanzee adenovirus ebola vaccine boosted with MVA nork Ewer (nee Russell), K, Rampling, T, Venkatraman, N, Bowyer, G, Wright, D, Lambe, T, Imoukhuede, E, Payne, R, Fehling, S, Strecker, T, Biedenkopf, N, Krähling, V, Tully, C, Edwards, N, Bentley, E, Samuel, D, Labbe, G, Jin, J, Gibani, M, Minhinnick, A, Wilkie, M, Poulton, I, Lella, N, Roberts, R, Hartnell, F, Bliss, C, Sierra-Davidson, K, Powlson, J, Berrie, E, Tedder, R, Roman, F, Ryck, I, Nicosia, A, Sullivan, N, Stanley, D, Mbaya, O, Ledgerwood, J, Schwartz, R, Siani, L, Colloca, S, Folgori, A, Di Marco, S, Cortese, R, Wright, E, Becker, S, Graham, B, Koup, R, Levine, M, Volkmann, A, Chaplin, P, Pollard, A, Draper, S, Ballou, W, Lawrie, A, Gilbert, S, Hill, A